Dr. Scott Armstrong

Biography

Scott Armstrong studies the mechanisms of cancer development, focusing on leukemia. His major interest lies in the relationship between leukemia and normal hematopoietic stem cells, elucidating the origins of leukemia. The Armstrong Lab is investigating the role of histone modifications and chromosome structure as critical initial steps in the mechanisms of cancer development that can be targeted therapeutically. His work has prompted the search for therapies aimed at reversing the processes that lead to cancer, resulting in new therapies tested on patients. Dr. Armstrong is the Chairman of Pediatric Oncology at Dana-Farber Cancer Institute and the Associate Chief of the Division of Hematology Oncology at Boston Children’s Hospital. Previously, he was the Director of the Center for Epigenetics Research at Memorial Sloan Kettering Cancer Center and a Professor of Pediatrics at Weill Cornell Medical College, where he initiated the cancer epigenetics research program, making significant contributions to the understanding of cancer biology. Dr. Armstrong received his M.D. and Ph.D. from the University of Texas Southwestern Medical School in Dallas, Texas, and performed his residency and fellowship in pediatric hematology/oncology at Children's Hospital Boston, Dana-Farber Cancer Institute, and Harvard Medical School. His major focus is delineating the biology of childhood cancers, particularly leukemia, and his work has led to the development of new therapeutic approaches for multiple types of cancer.

Research Interests

Awards